Xilio Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Xilio Therapeutics's balance sheet done over the years? Its assets were worth $60,926,000 last year, which is less than in the previous period. 40% of Xilio Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $24,099,000, which means an decrease by -28% compared compared to last year.

Debt to Assets

Xilio Therapeutics, Inc. (NASDAQ:XLO): Debt to assets
2019 62722000 92.24M 147.07%
2020 36317000 119.60M 329.33%
2021 218060000 32.63M 14.96%
2022 139165000 33.51M 24.09%
2023 60926000 24.09M 39.55%

XLO Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
44.70M120.38M198.05M19.23M48.84M
Short term investments
00000
Net receivables
00000
Inventory
00000
Other current assets
3.42M4.11M4.46M44K1.00M
Total current assets
48.12M124.49M202.51M20.59M51.10M
Non-current assets:
Property, Plant and Equipment
11.20M12.84M13.59M13.67M9.87M
Goodwill
00000
Intangible assets
00000
Long term investments
01.56M1.55M1.55M194K
Other non-current assets
1.59M267K1.94M500K1.55M
Total non-current assets
12.79M14.66M15.54M15.72M11.61M
Total assets
60.92M139.16M218.06M36.31M62.72M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
008.75M13.73M0
Short term debt
3.31M7.58M801K2.89M0
Total current liabilities
15.95M21.11M12.77M22.15M5.20M
Non-current liabilities:
Long term debt
8.14M12.35M19.73M18.32M18.63M
Deferred tax
00000
Other non-current liabilities
145K118K79.12M68.40M
Total non-current liabilities
8.14M12.39M19.85M97.44M87.03M
Total liabilities
24.09M33.51M32.63M119.60M92.24M
Data sourceData sourceData source